精神心理科指南

订阅

MedSci主页 / 所有栏目 / 精神心理科指南

2021 CANMAT/ISBD建议：双向障碍伴混合特征患者的管理

2021-10-02 加拿大情绪和焦虑治疗网络 Bipolar Disord

双向情感障碍

2021年10月，加拿大情绪和焦虑治疗网络(CANMAT)、国际双相情感障碍联盟(ISBD)发布了双向障碍伴混合特征患者的管理建议。本文主要针对双向障碍伴混合特征患者的管理提供指导建议。

中文标题：

2021 CANMAT/ISBD建议：双向障碍伴混合特征患者的管理

英文标题：

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations

发布机构：

加拿大情绪和焦虑治疗网络

发布日期：

2021-10-02

简要介绍：

2021年10月，加拿大情绪和焦虑治疗网络(CANMAT)、国际双相情感障碍联盟(ISBD)发布了双向障碍伴混合特征患者的管理建议。本文主要针对双向障碍伴混合特征患者的管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 CANMAT／ISBD建议：双向障碍伴混合特征患者的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2bfe51c0022015ca, title=2021 CANMAT/ISBD建议：双向障碍伴混合特征患者的管理, enTitle=Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations, guiderFrom=Bipolar Disord, authorId=0, author=, summary=2021年10月，加拿大情绪和焦虑治疗网络(CANMAT)、国际双相情感障碍联盟(ISBD)发布了双向障碍伴混合特征患者的管理建议。本文主要针对双向障碍伴混合特征患者的管理提供指导建议。, cover=https://img.medsci.cn/2021109/1633771826433_5579292.jpg, journalId=0, articlesId=null, associationId=582, associationName=加拿大情绪和焦虑治疗网络, associationIntro=null, copyright=0, guiderPublishedTime=Sat Oct 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年10月，加拿大情绪和焦虑治疗网络(CANMAT)、国际双相情感障碍联盟(ISBD)发布了双向障碍伴混合特征患者的管理建议。本文主要针对双向障碍伴混合特征患者的管理提供指导建议。</span></p>, tagList=[TagDto(tagId=19278, tagName=双向情感障碍)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=19278, guiderKeyword=双向情感障碍, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6252, appHits=121, showAppHits=0, pcHits=2807, showPcHits=6131, likes=1, shares=9, comments=14, approvalStatus=1, publishedTime=Sat Oct 09 17:31:29 CST 2021, publishedTimeString=2021-10-02, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Oct 09 17:30:37 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 09:14:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 CANMAT／ISBD建议：双向障碍伴混合特征患者的管理.pdf)])
2021 CANMAT／ISBD建议：双向障碍伴混合特征患者的管理.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1231915, encodeId=bee1123191576, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45048231923, createdName=ms8000000549701108, createdTime=Mon Jul 11 23:33:11 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059338, encodeId=dcb11059338fb, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Mon Oct 11 08:58:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059207, encodeId=d743105920e08, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:38 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059160, encodeId=803d105916070, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16085629374, createdName=ms8000001808779367, createdTime=Sun Oct 10 12:25:57 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059133, encodeId=0639105913332, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/58e01f5adcbf4aae90dfc25bd03c739f/1aca8d53476d43fca347e4819bda61f4.jpg, createdBy=b2d85436799, createdName=Lizhihua6, createdTime=Sun Oct 10 10:29:42 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2022-07-11 ms8000000549701108

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1231915, encodeId=bee1123191576, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45048231923, createdName=ms8000000549701108, createdTime=Mon Jul 11 23:33:11 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059338, encodeId=dcb11059338fb, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Mon Oct 11 08:58:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059207, encodeId=d743105920e08, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:38 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059160, encodeId=803d105916070, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16085629374, createdName=ms8000001808779367, createdTime=Sun Oct 10 12:25:57 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059133, encodeId=0639105913332, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/58e01f5adcbf4aae90dfc25bd03c739f/1aca8d53476d43fca347e4819bda61f4.jpg, createdBy=b2d85436799, createdName=Lizhihua6, createdTime=Sun Oct 10 10:29:42 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2021-10-11 hannah1001

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1231915, encodeId=bee1123191576, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45048231923, createdName=ms8000000549701108, createdTime=Mon Jul 11 23:33:11 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059338, encodeId=dcb11059338fb, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Mon Oct 11 08:58:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059207, encodeId=d743105920e08, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:38 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059160, encodeId=803d105916070, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16085629374, createdName=ms8000001808779367, createdTime=Sun Oct 10 12:25:57 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059133, encodeId=0639105913332, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/58e01f5adcbf4aae90dfc25bd03c739f/1aca8d53476d43fca347e4819bda61f4.jpg, createdBy=b2d85436799, createdName=Lizhihua6, createdTime=Sun Oct 10 10:29:42 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2021-10-10 ms6000001387765207

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1231915, encodeId=bee1123191576, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45048231923, createdName=ms8000000549701108, createdTime=Mon Jul 11 23:33:11 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059338, encodeId=dcb11059338fb, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Mon Oct 11 08:58:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059207, encodeId=d743105920e08, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:38 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059160, encodeId=803d105916070, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16085629374, createdName=ms8000001808779367, createdTime=Sun Oct 10 12:25:57 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059133, encodeId=0639105913332, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/58e01f5adcbf4aae90dfc25bd03c739f/1aca8d53476d43fca347e4819bda61f4.jpg, createdBy=b2d85436799, createdName=Lizhihua6, createdTime=Sun Oct 10 10:29:42 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2021-10-10 ms8000001808779367

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1231915, encodeId=bee1123191576, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45048231923, createdName=ms8000000549701108, createdTime=Mon Jul 11 23:33:11 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059338, encodeId=dcb11059338fb, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4f75559630, createdName=hannah1001, createdTime=Mon Oct 11 08:58:24 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059207, encodeId=d743105920e08, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:38 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059160, encodeId=803d105916070, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16085629374, createdName=ms8000001808779367, createdTime=Sun Oct 10 12:25:57 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059133, encodeId=0639105913332, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/58e01f5adcbf4aae90dfc25bd03c739f/1aca8d53476d43fca347e4819bda61f4.jpg, createdBy=b2d85436799, createdName=Lizhihua6, createdTime=Sun Oct 10 10:29:42 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2021-10-10 Lizhihua6

    学习了

    0

相关指南

2015 AHA科学声明：重度抑郁症和双相情感障碍会导致年轻人加速性动脉粥样硬化和早期心血管疾病  

美国心脏协会(AHA,American Heart Association) · 2015-08-10

拓展阅读

2015 AHA科学声明：重度抑郁症和双相情感障碍会导致年轻人加速性动脉粥样硬化和早期心血管疾病  

美国心脏协会(AHA,American Heart Association) · 2015-08-10

2021 CANMAT/ISBD建议：双相障碍伴混合特征患者的管理

加拿大情绪和焦虑治疗网络(CANMAT,Canadian Network for Mood and Anxiety Treatments) · 2021-10-02